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THE EXPRESSION OF INHERITED
METABOLIC DISEASE IN CULTURED CELLS*t
ALEXANDER G. BEARN
Department of Medicine,
The New York Hospital-Cornell Medical Center,
New York, New York
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I. INTRODUCTION

HE Harvey Society of New York was founded 70 years ago to
commemorate the name of one who, with the publication of De
Motu Cordis, provided definitive evidence for the circulation of blood
and established the abiding, but then novel, principle that scientists
should not complacently recycle the conventional wisdom of the past.
Rather they should, and I now use Harvey's stirring imperative, "Search
out and study the secrets of Nature by way of experiment."
Harvey, in addition to being a scientist was a busy medical practi
tioner, and in the course of his daily practice, he might well have
encountered patients suffering from inherited disease. While Harvey is,
of course, best known for De Motu Cordis, he published in the 73rd
year of his life, his second great work De Generatione Animalium.
Although a scrutiny of De Generatione failed to provide the hoped for
evidence that Harvey was aware of the existence of inherited disease,
there is an extraordinary letter extant, first quoted in full by Garrod in
his Harveian Lecture in 1924 (Garrod, 1924), which shows that Harvey
was 300 years ahead of his time in appreciating that the study of rare
diseases clarifies normal biological and biochemical mechanisms. Har
vey's last correspondent was Dr. Jon Vlackfeld, a practitioner living in
Haarlem who had consulted him regarding a patient of his that was
suffering from stone (Keynes, 1966) (Fig. 1). The paucity of any
documentary evidence bearing on Harvey's medical interests can be
*Lecture delivered February 20, 1975.
tThis work was supported in part by a grant from the National Foundation
March of Dimes, U.S. Public Health Service Grant No. 11796 and The National
Cystic Fibrosis Foundation.
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Learned Sir,
There has come to me your very pleasant letter, in which you show both
extreme goodwill towards myself and also exceptional industry in the cultivation
of our art.
It is indeed so. Nature is nowhere wont to reveal her innermost secrets more
openly than where she shows faint traces of herself away from the beaten track.
Nor is there any surer route to the proper practice of medicine than if someone
gives his mind over to discerning the customary law of Nature through the careful
investigation of diseases that are of rare occurrence. Indeed, in practically all
things it is apparently arranged that we scarcely perceive what is useful or most
serviceable in them unless some are lacking in these features or have a faulty
disposition. The case of the plasterer you mention is certainly an unique instance,
in the elucidation of which it is possible for much discussion to arise. But it is
useless for you to spur me on and for me to gird myself for some new research
when I am not only ripe in years but also-let me admit-a little weary. It seems
to me, indeed, that I am entitled to ask for an honourable discharge. On the other
hand, it will always be a pleasure to me to see distinguished gentlemen such as
yourself engaged in such worthy contest. Farewell, elegant Sir, and whatever you
do, continue to hold in affection
Yours respectfully,
William Harvey
London, 24 April 1657
FIG. 1. William Harvey's reply to a letter from Dr. Jon Vlackfeld of Haarlem.
Harvey died later that year.

laid, at least in part, on governmental interference. With the execution
of Charles I, Harvey lost his patient and his friend. He loathed the
Parliamentary regime that followed·, and they in turn, showed no
fondness for him. In a remarkable action, Parliament expressly forbade
him to come within 20 miles of the City of London even to those of his
patients.who needed medical attention (Whitteridge, 1971).
Not content with this infringement of liberty, Parliament in the
winter of 1642-1643 plundered Harvey's lodgings at Whitehall and
pillaged not only his worldly goods but his entire medical records. And,
when in 1666 the Great Fire destroyed the College, all hope of learning
more about the medical interests of William Harvey was gone forever
(Whitteridge, 1971, 1974).
An interesting historical link between the Harvey Society and ge
netics arises from the fact that in the same year that the Harvey
Society was founded in New York, William Bateson made the sug
gestion that the word "Genetics" be used to cover the emerging field of
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hereditary variation (Bateson, 1928). The ensuing 70 years have
seen the science of genetics emerge as the axial thread of biology with
great relevance not only to those whose principal activities are rooted in
laboratory research of the most fundamental sort, but also to physi
cians whose primary concern is the alleviation of suffering and the
prevention and treatment of disease.
Since 1900 improvements in general hygiene, and the development of
antibiotic therapy have enabled many of the epidemic infectious dis
eases, particularly those of infancy and early childhood, increasingly to
be controlled. In contrast, the morbidity and mortality of diseases of
genetic origin have been little affected. A recent survey of the patients
in the Department at New York Hospital-Cornell Medical Center,
disclosed that no less than 12% of patients admitted to the adult
medical service suffer from diseases in which a genetic component can
be recognized (Childs et al., 1972). It is variously estimated that
approximately 3% of the population at birth are afflicted with a
genetically determined disease, a figure that would be even more
substantial if the base line consisted of all zygotes conceived, rather
than infants born. The rapid increase in the number of inherited
conditions that are now known is illustrated in Fig. 2.
II. HISTORICAL DEVELOPMENT
Ross Harrison, in his Harvey Lecture delivered in 1908, described
experiments that marked the dawn of modern tissue culture (Harrison,
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FIG. 2. Recognition of human gene loci (1966-1974). (After McKusick, 1975.)

78

ALEXANDER G. BEARN

1908). When the embryonic spinal cord of the frog surrounded by
lymph was sealed in a chamber, the cord cells not only remained viable,
but from them there developed the outgrowth of nerve axons. These
observations, at one and the same time provided the coup de grace to
those who were still stubbornly adhering to the view that the nerve
axon and the nerve cell were separate and unconnected bodies, and also
established the powerful usefulness of cell culture in answering impor
tant biological questions. Here at The Rockefeller Institute, Harrison's
observations were quickly seized upon by Alexis Carrel. Carrel found,
all too quickly, that a major deterrent to the successful cultivation of
cells in vitro was the frequency with which they became contaminated
with bacteria. To combat this difficulty, Carrel devised complicated and
bizarrely arcane rituals, including insistence that a black gown and cap
were a necessary prerequisite for those who would dare to venture on
the treacherous seas of tissue culture. Slowly, however, black magic and
alchemy yielded to science and orthodoxy, and tissue culture as a tool
in biological research is now firmly established (Carrel, 1964; Beam,
1972).
The rational use of cell culture as an investigative technique in
inherited metabolic disease is rooted in the simple biologic truth that,
since a full complement of chromosomes is present in all somatic cells,
it should be possible to detect the specific biochemical consequences of
gene activity in cultured fibroblasts unless, during the process of dif
ferentiation, genes are irreversibly inactivated.
III. THE HURLER AND HUNTER SYNDROMES
Rather more than 10 years ago, our laboratory embarked on an
investigation to see whether the inherited mucopolysaccharidoses could
be studied profitably in cultured fibroblasts. The mucopolysacchari
doses are rare inborn errors of metabolism, to use the phrase introduced
by Garrod in his epoch making Croonian Lectures in 1908 (Garrod,
1908), that result in an accumulation of mucopolysaccharides in vari
ous issues of the body. The diseases are characterized by mental
deficiency and dwarfism, as well as a variety of other signs and symptoms
(McKusick, 1972). The two most common forms of the disease are
colloquially known as Hurler's syndrome and Hunter's syndrome, the
former being autosomally inherited, the latter X-linked.
An increased hepatic storage of mucopolysaccharides in patients
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dying from the disease was first reported by Brante (1952). Later
Dorfman and Lorinz (1957), and Meyer and associates (1958) reported
an increased urinary excretion of mucopolysaccharides in these dis
eases. In 1965, Berggftrd extended these studies in our laboratory, and
although he was able to confirm the increased urinary excretion of
mucopolysaccharides in patients affected with the disease, he was
unable to distinguish clinically unaffected heterozygous carriers from
normal subjects (Berggftrd and Beam, 1965). He made the interesting
prediction that, since both dermatan sulfate and heparan sulfate con
tained iduronic acid and since both mucopolysaccharides were excreted
in excess in the urine, "the mutations might affect enzymes partici
pating in the metabolism of iduronic acid" (Berggftrd and Beam, 1965).
In an attempt to circumvent the time-consuming chemical determina
tions necessary to identify specific mucopolysaccharides, we first inves
tigated the possibility that histological methods could be used to
identify the presence of mucopolysaccharides in cells grown in tissue
culture.
It is well known that the thiazine dye toluidine blue O will form
complexes with a variety of negatively charged tissue components.
When they do so, there is a shift in the absorption maxima of the dye
toward a shorter wavelength. This will result in metachromasia, a
change in color from the orthochromatic blue through violet to red. A
certain minimum surface charge density is required for metachromasia
to become apparent. Thus, with the polysaccharide hyaluronic acid,
where the distance between the carboxyl groups is 19-30 A, meta
chromasia is usually not evident. However, with the introduction of
sulfate ester groups, the intercharge difference is sharply reduced and
results in strong and stable red metachromasia. Thus the mucopolysac
charides dermatan sulfate, heparan sulfate and keratan sulfate all stain
metachromatically.
Fibroblasts derived from patients with the Hurler and Hunter syn
dromes show distinct cytoplasmic metachromasia (Danes and Beam,
1966a), which can be shown by chemical methods to be due to
increased cellular uronic acid. The cells derived from the heterozygous
parents of the autosomally inherited Hurler syndrome show a similar
metachromatic appearance. Although these tinctorial alterations also
indicate that the heterozygous carrier can be detected in tissue culture,
the degree of staining is similar in both affected individuals and unaf
fected heterozygotes, and the test cannot be used to distinguish hetero-
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zygotes in the general population. In the X-linked Hunter syndrome,
the cells derived from the carrier mother also show similar staining
characteristics. Cloning experiments performed on cells derived from
the X-linked mothers of patients with Hunter syndrome indicate the
presence of two distinct tinctorial pop'ulations (Danes and Beam,
1967). In the metachromatic population it appears that the X chromo
some bearing the normal gene has been inactivated, whereas in the
population of cells which show no metachromasia the chromosome
bearing the abnormal gene has been inactivated. These findings provide
additional experimental evidence for the validity of the Lyon hypoth
esis (1962). In contrast, all cells derived from the mothers of patients
with the autosomally inherited Hurler's syndrome show metachromasia,
confirming that the Lyon hypothesis does not obtain for the auto
somes.
The co-cultivation of cells derived from patients with the Hurler
syndrome and the Hunter syndrome result in a population of cells
which, by their tinctorial characteristics, cannot be distinguished from
those derived from normal individuals. The corrective factors have been
extensively investigated by Neufeld and her co-workers (Fratantoni et
al., 1968; Neufeld, 1973), who showed that the rapid accumulation of
sulfated mucopolysaccharides that occurs when the cells from Hurler
syndrome and Hunter syndrome are cultivated in vitro does not arise if
the two cell populations are mixed (Fig. 3). In addi�ion, they also
showed that correction can be obtained by the use of culture medium
and does not require cell-to-cell contact.
Additional studies by Neufeld have shown the specific enzyme sul
foiduronate sulfatase is deficient in the cells of patients with the Hunter
syndrome whereas a-L-iduronidase is deficient in the cells of patients
with the Hurler syndrome. It was of particular interest that O'.-L-iduroni
dase was also decreased in the Scheie syndrome, as variant of the Hurler
syndrome, in which intellectual function is preserved (Fig. 4) (Neufeld,
1974). The observation that the same enzyme was apparently affected
in both raised the possibility that the two syndromes are euallelic, in
the same way that the genes controlling the synthesis of hemoglobin S
and hemoglobin C are euallelic: Euallelism would permit the existence
of mixed Hurler/Scheie heterozygotes analogous to hemoglobin
S/hemoglobin C heterozygotes. At least eight patients have now been
identified in whom the clinical phenotype has features of both the
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FIG. 3. Accumulation of mucopolysaccharides (MPS) in normal cells(--),
in in vitro-cultivated Hurler syndrome(....) and Hunter syndrome(- - - -) cells,
and in mixed Hurler and Hunter syndromes cells(·-·-). After Neufeld(1973).

Hurler and Hunter syndromes and in whom there is a deficiency of
a-L-iduronidase (McKusick et al., 1972). Kinetic and metabolic studies
should help to clarify, at the molecular level, possible structural and
functional differences between the enzymes defective in the two syn
dromes.
The usefulness of tissue culture in investigating inherited metabolic
disease does not rest with the biochemical identification of the primary
defect. The cells in culture provide a model system of the disease,
which can be used to test the possible effectiveness of therapeutic
agents. The administration of purified enzyme to patients in whom an
enzyme is defective will not be effective unless the enzyme gains access,
and in sufficient quantities, to the cell compartment where the enzymic
function is required. Although it has not proved to be therapeutically
beneficial, it is of interest, in view of its known action on lysosomes,
that vitamin A can reverse the tinctorial characteristics of the mutant
cells when added in vitro (Danes and Beam, 1966b). Although the
elucidation of the biochemical defect in patients with most of the
known mucopolysaccharidoses has now been accomplished there are
many inherited diseases, far more common than the mucopolysacchari
doses, where the underlying defect remains utterly obscure.
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IV. CYSTIC FIBROSIS OF THE PANCREAS
Cystic fibrosis is the most frequently occurring autosomally inherited
disease -affecting the white population (Table I). It occurs in all popula. tions but appears to be distinctly less common in the Oriental and
Black populations. The disease was probably first recognized by Garrod
and Hurtley (1912), who believed it was an inherited disorder of fat
metabolism in which fats were not absorbed from the alimentary tract
in normal quantities.. He was led to believe that the disease was
autosomally inherited since the normal parents of the affected sibs were
first cousins. [It is of some interest that, in fact, an increased consan
guinity would not be expected in a homogeneous recessively inherited
disease of the frequency of cystic fibrosis.] The first clue that there
might be a biochemical defect in cystic fibrosis came from astute
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clinical observations. The late summer of 1948 was characterized by a
heat wave of short duration but high intensity, and in the space of 4
days, 10 patients were admitted to the Babies Hospital of the College of
Physicians and Surgeons with heat stroke, six of whom had cystic
fibrosis (Fig. 5) (Kessler and Andersen, 1951). It was quickly appre
ciated that if the patients with cystic fibrosis lost excessive salt in their
sweat compared to the four other patients, an explanation for the
circulatory collapse would be at hand. Studies by di Sant' Agnese and
his colleagues (1953) demonstrated an increased sweat sodium in the
patients with cystic fibrosis, and an increased sweat sodium is now the
most reliable diagnostic test for the disease, particularly in childhood.
The increased sweat sodium is now recognized to be the consequence of
the presence of a factor, known colloquially as the Mangos factor after
its discoverer, which is present in the sweat of patients with the disease
and inhibits the normal reabsorption of salt (Mangos and McSherry,
1967). The factor occurs in small quantities and, apart from knowing
that it is protein in nature, its isolation and characterization has been
difficult. As a result of the studies on the defect in salt excretion, the
view gained prominence that the disease was primarily a disorder of the
exocrine system, a view that gained credence from the known abnor
mality in pancreatic and bronchial secretions. However, in view of our
findings with the mucopolysaccharidoses and because in principle the
genetic defect should be present in every cell, we turned to tissue
culture, using the same techniques that had previously been useful in
investigating the mucopolysaccharidoses.
The initial studies indicated that, as in the mucopolysaccharidoses,
the cells derived from patients with cystic fibrosis showed meta
chromasia (Danes and Beam, 1969a). This metachromasia, which also

TABLE I
CYSTIC FIBROSIS OF THE PANCREAS
Incidence
Inheritance
Population variation
Frequency heterozygote

1/2500 Live births
Autosomal recessive
Rare in Orientals and Blacks
1/25
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FIG. 5. Relation of ambient temperature to patients admitted to Babies Hospi
tal, New York City, with circulatory collapse (August-September 1948). ■, Cystic
fibrosis; �. non-cystic fibrosis. 1 rectangle represents 1 patient. After Kessler and
Andersen (1951).

occurred in the heterozygotes, could not be distinguished from that
occurring in the mucopolysaccharidoses and certain other diseases.
However, the increased mucopolysaccharide content so characteristic of
the mucopolysaccharidoses was not regularly observed in the cells from
patients with cystic fibrosis (Danes and Beam, 1969b ). Moreover,
whereas the cells from patients with the mucopolysaccharidoses stained
with alcian blue at high electrolyte concentrations, the cells from the
cystic fibrosis patients did not (Danes et al., 1970). As the study
progressed, it was apparent that not all patients with cystic fibrosis had
metachromatically stained fibroblasts and, further, that the proportion
of patients showing metachromasia differed in different populations
(Table II). Although there does not appear to be a clear-cut correlation
between the presence or the absence of metachromasia and the clinical
findings, recent studies by Danes et al. (1975), in which they studied an
adult population of patients with cystic fibrosis at the Brampton
Hospital, the frequency of metachromasia was found to be over 90%
(Table II). It cannot be sufficiently emphasized that, although meta
chromasia is usually observed in the heterozygous parents of patients in
whom metachromasia is present, the test is difficult, at times unpre
dictable, and cannot be used to detect heterozygotes with the disease.
This is further emphasized by those families in whom this cell marker
cannot be detected even in those clinically affected (Beam and Danes,
1969).
In 1956, Alexander Spock made the curious but important observa
tion that serum from patients with cystic fibrosis contained a substance
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TABLE II
PROPORTION OF PATIENTS SHOWING METACHROMASIA IN
DIFFERENT POPULATIONS
Population

Number of
patients

Metachromatic

Ametachromatic

New York City
Minneapolis
Denmark
England (adults)

30
27
87
42

26
22
56
39

4 (13%)
5 (19%)
31 (35%)
3 (7%)

that had the property of disorganizing the synchronous movements of
oyster cilia derived from rabbit tracheal ex plants (Spock et al., 1967).
This factor, now known as the Spock factor, bears some similarity to
the Mangos factor in that it is protein in nature. As with the Mangos
factor, isolation and detailed characterization of the factor has been
difficult.
A systematic attempt to investigate other ciliated organisms, in an
effort to find a simpler biological system, led Bowman and her col
leagues to investigate oyster cilia (Bowman et al., 1969, 1970, 1973).
Although many investigators prefer the rabbit tracheal system (Conover
et al., 1973), we have used the oyster (Crassostrea virginica) in our
studies in cystic fibrosis.
Although the addition of normal serum had no effect on the syn
chronous beating of oyster cilia, the addition of serum from patients
with cystic fibrosis, as well as the serum of patients who are hetero
zygous carriers, usually caused the cessation of movement within 60
seconds. The test, like nearly all biological tests, is highly variable and
very subjective. Duplicate samples must always be obtained and the
tests run in a double-blind fashion. Even when these precautions are
taken, there are many occasions when the test is unsatisfactory. In the
summer months, as Bowman has shown, the excessive production of
mucus by the oyster makes the test essentially useless (Lockhart and
Bowman, 1973). Despite these limitations, the test is providing con
crete evidence of the presence of a substance in the serum of most
patients with cystic fibrosis which inhibits the cilia. It is also of interest
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that serum from heterozygous as well as homozygous individuals, which
consistently does not inhibit the cilia, is usually derived from patients
in whom metachromasia is not apparent in their cultured cells.
Although the isolation and characterization of cystic fibrosis from
cystic fibrosis serum has not been accomplished, a number of properties
have been described (Bowman et al., 1973; Danes et al., 1973; Bow
man, 1973). Prominent among these has been the finding that the
factor is associated with the ')'-globulin fraction of serum (Fig. 6).
However, the possibility that the factor was itself an antibody was
excluded by the immunological studies of Bowman and her colleagues
(Herzberg et al., 1973). Synthesis of the factor by cultured fibroblasts
was established by growing cells derived from patients with cystic
fibrosis in a synthetic protein-free medium. When purified lgG was
added to the protein-free cultured fluid, the cystic fibrosis factor
emerged associated with lgG in the void volume (Fig. 7). The properties
of cystic fibrosis compiled from several sources are summarized in
Table III.
Although the appearance of the "factor" in the serum of patients is
of extreme interest, its exact nature and its relevance to the primary
defect are obscure. Presumably the defect, in conformity with other

0.25
DEAE - Cellulose
pH 8.5

0.20

A280nm

1.15
� Ciliory inhibitor
+
lgG

1.10

10

30

50

FIG. 6. Serum protein fraction derived from patient with cystic fibrosis sepa
rated by column chromatography. The ciliary inhibitor is eluted with the lgG
fraction.
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inborn errors of metabolism, is one that affects a specific enzyme. It is
possible that the presence of the factor in the serum represents the
accumulation of a substance behind an enzymatic metabolic block. The
cystic fibrosis factor, according to this hypothesis, might be a normal
serum component that occurs in increased concentration in patients
with cystic fibrosis. The small molecular weight of the cystic fibrosis
factor raised the possibility, among the many others, that the factor

TABLE III
PROPERTIES OF CYSTIC FIBROSIS FACTOR
Molecular weight
Isoelectric focusing
Inactivation

4,500-10,000 Daltons (Gel filtration Ainicon filters)
pH 9.10-9.30
Pepsin pH 3.8
Papain pH 8.5
Heat 50° C for 15 min

Reaction with serum proteins
Binds: IgG (IgGl, IgG2) �2 M, heavy chains
No binding: IgA , IgM, IgD, Fab, Fe, light chains
Haptoglobin
Group-specific component

Human Fibroblast
(46)

Mouse Hepatoma
(59)

Protein

· Hybrid
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FIG. 8. Fusion of human fibroblasts and mouse hepatoma cells yield a hybrid that synthesizes immunologically
det�ctable human serum albumin. Control studies indicate the specificity of the albumin synthesized. Abbreviations: FIB,
Fibroblasts; HSA, Human serum albumin; MSA, Mouse serum albumin; HEP, Mouse hepatoma; FCS, Fetal calf serum;
BUF, Buffer; AH, Antihuman albumin; AM, Antimouse albumin; HYB, Hybrids.
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might be related to the complement system. This possibility has been
investigated by Conover and his colleagues (1973b) as well as by
ourselves (Polley and Beam, 1974). An outline of the preliminary
studies carried out in our laboratory indicate that the third component
of compiement is usually decreased; in addition there is a decreased
conversion of C3 proactivator (Polley and Beam, 1974). Moreover, the
incubation of purified C3 by trypsin under conditions that split C3 into
C3a and smaller tryptic fragments indicates that the small-molecular
weight peptides inhibit oyster cilia whereas C3, as well as the split
products C3b and C3a, have no inhibitory effect (Polley and Beam,
197 5). Although further studies on the possible relevance of the com
plement system to cystic fibrosis are in progress, it seems likely that
any abnormality in this system is of secondary importance.
Although the application of cell culture to investigating inherited
metabolic disease has been restricted, in this presentation, to two main
groups of diseases, more than 70 inherited diseases have been investi
gated using these techniques, and their number continues to increase.
Already, many of these diseases can be detected prenatally by the
cultivation of fetal cells obtained by amniocentesis, and in those in
stances where prenatal detection can be reliably performed the pos
sibility of selective abortion can be entertained.
The recent use of mouse hepatoma human hybrids as developed by
Darlington and her colleagues (1974) has raised the possibility that
under appropriate experimental conditions liver-specific proteins, such
as serum albumin, can be synthesized by normal human fibroblasts. The
synthesis of human serum albumin by cultured fibroblasts following the
fusion of mouse hepatoma cells with normal human fibroblasts is
illustrated in Fig. 8. If, as seems likely, the findings obtained thus far
can be extended to other organ-specific proteins, the possibility arises
that inherited diseases in which the metabolic abnormality appears to
be restricted to a specific differentiated organ may be approached by
the use of cell hybridization techniques. It is clear that the usefulness of
cell culture in the study of inherited disease is still in its infancy.
ACKNOWLEDGMENTS

I am indebted to my colleague Dr. B. Shannon Danes with whom much of
the work reported in this paper was carried out and who kindly assisted in the
preparation of the manuscript. Some of the preliminary experiments in tissue

90

ALEXANDER�BEARN

culture were carried out in collaboration with James L. German and Dr.
Ingemar Berggard at The Rockefeller University. It was from these early begin
nings that the studies in tissue took root. I am particularly indebted to my
colleagues Hartwig Oeve, Kathleen Foley, Shigeru Fugita, Thomas Hiitteroth,
Stephen Litwin, Margaret Polley, and John Scott, who over the years have
contributed so much to the ideas and substance of the work reported in this
lecture.
REFERENCES
Bateson, W. (1928). In "Essays and Addresses," p. 93. Cambridge Univ. Press,
London and New York.
Beam, A.G. (1972). N. Engl. J. Med. 286, 764.
Beam, A. G., and Danes, B. S. (1969). Trans. Assoc. Am. Phys. 82, 248.
Bergg?ud, I., and Bearn, A.G. (1965). Am. J. Med. 39,221.
Bowman, B. H. (1973). Tex. Rep. Biol. Med. 31(Special Section), 611.
Bowman, B. H., Lockhart, L. H., and Mc Combs, M. L. (1969). Science 164,325.
Bowman, B. H., McCombs, M. L., and Lockhart, L. H. (1970). Science 167,871.
Bowman, B. H., Barnett, D. R., Matalon, R., Danes, B. S., and Beam, A. G.
(1973). Proc. Natl. Acad. Sci. U.S.A. 70, 548.
Brante,G. (1952). Scand. J. Clin. Lab. Invest. 4,43.
Carrel, A. (1964). In "Nobel Lectures. Physiology or Medicine. 1942-1962" p.
444. Elsevier, Amsterdam.
Childs, B., Miller, S. M., and Beam, A. G. (1972). In "Mutagenic Effects of
Environmental Contaminants" (H. E. Sutton and M. I. Harris, eds.), p. 3.
Academic Press, New York.
Conover, J. H., Bonforte, R. J., Hathaway, P., Paciuc, S., Conod, E. J., Hirschhorn, K., and Kopel, F. B. (1973a). Pediat. Res. 7,220.
Conover, J. H., Conod, E. J., and Hirschhorn, K. (1973b). Lancet 2,1501.
Danes, B. S., and Beam, A.G. (1966a). J. Exp. Med. 123, 1.
Danes, B. S., and Beam, A.G. (1966h). J. Exp. Med. 124, 1181.
Danes, B. S., and Beam, A.G. (1967). J. Exp. Med. 126,509.
Danes, B. S., and Beam, A.G. (1969a). J. Exp. Med. 129,775.
Danes, B. S., and Bearn, A. G. (1969b). Biochem. Biophys. Res. Commun. 36,
919.
Danes, B. S., Scott, J. E., and Beam, A.G. (1970). J. Exp. Med. 132, 765.
Danes, B. S., Litwin, S. D., Hiitteroth, T. H., Cleve, H., and Beam, A.G. (1973).
J. Exp. Med. 137, 1538.
Danes, B. S., Hodson, M. E., and Batten, J. (1975). Unpublished data.
Darlington,G. J., Bernhard, H.P., and Ruddle, F. H. (1974). Science 185,859.
di Sant'Agnese, P.A., Darling, R. C.,Perera,G. A., and Shea, E. (1953). Pediatrics
12, 549.
Dorfman, A., and Lorincz, A. E. (1957). Proc. Natl. Acad. Sci. U.S.A. 43,443.
Fratantoni, J. C., Hall, C. W., and Neufeld, E. F. (1968). Proc. Natl. Acad.· Sci.
U.S.A. 60,699.
Garrod, A. E. (1908). Lancet 2,1, 73, 142,214.

INHERITED METABOLIC DISEASE

91

Garrod, A. E. (1924). Br. Med. J, October 25, p. 747.
Garrod, A. E., and Hurtley, W. H. (1912). Quart J Med. 6,242.
Harrison,R.G. (1907-8). Harvey Leet. Ser. 3, 199.
Herzberg, V., Clavert, L., and Bowman, B. H. (1973). J. Clin. Invest. 52,2732.
Kessler, W.R., and Andersen, D. H. (1951). Pediatrics 8,648.
Keynes, G. (1966). "The Life of William Harvey," p. 368. Oxford Univ. Press,
(Clarendon), London and New York.
Lockhart, L. H., and Bowman, B. H. (1973). Tex. Rep. Biol. Med. 31,631.
Lyon, M. F. (1962). Am. J. Hum. Genet. 14,135.
McKusick, V. A. (1972). 'Heritable Disorders of Connective Tissue," 4th ed., p.
521. Mosby, St. Louis, Missouri.
McKusick, V. A. (1975). "Mendelian Inheritance in Man. Catalogs of Autosomal
Dominant, Autosomal Recessive, and X-Linked Phenotypes," 4th ed, Johns
Hopkins Press, Baltimore, Maryland.
McKusick, V. A., Howell,R. R., Hussels, I. E., Neufeld, E. F., and Stevenson,R.
E. (1972). Lancet 1,993.
Mangos, J. A., and McSherry, N. R. (1967). Science 158,135.
Meyer, K.,Grumbach, M. M., Liker, A., and Hoffman, P. (1958). Proc. Soc. Exp.
Biol. Med. 91,275.
Neufeld, E. F. (1973). In "Medical Genetics" (V. A. McKusick andR. Claiborne,
eds.), p. 141. HP Puhl., New York.
Neufeld, E. F. (1974). In "Progress in MedicalGenetics" (A. G. Steinberg and A.
G. Beam, eds.), Vol. 10, p. 81.Grune & Stratton, New York.
Polley, M. J., and Beam, A.G. (1974). J Med. Genet. 11,249.
Polley, M. J., and Beam, A.G. (1975). Unpublished data.
Spock, A., Heick, H. M. C., Cress, H., and Logan, W. S. (1967). Pediat. Res. 1,
173.
Whitteridge, G. (1971). "William Harvey and the Circulation of the Blood."
MacDonald, London.
Whitteridge, G. (1974 ). Personal communication.
ADDENDUM (July 1976)
In the 18 months that have elapsed since the delivery of this lecture, the
primary metabolic defects in most of the mucopolysaccharidoses have been
determined. The number of inherited diseases detectable in tissue culture con
tinues to increase and the number of instances where accurate prenatal diagnosis
can be made is also increasing rapidly (McKusick, 1975). Although the number of
reported metabolic aberrations in cystic fibrosis shows no signs of abatement, the
primary enzymatic defect remains elusive.

